Graham Capital Management
NVCR icon

Graham Capital Management’s NovoCure NVCR Stock Holding History

Graham Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,857
Closed -$502K – 1408
2025
Q4 		$502K Buy
38,857
+28,762
+285% +$369K 0.01% 626
2025
Q3 		$130K Sell
10,095
-17,950
-64% -$240K ﹤0.01% 1135
2025
Q2 		$499K Sell
28,045
-23,746
-46% -$414K 0.01% 821
2025
Q1 		$923K Buy
51,791
+30,082
+139% +$683K 0.02% 578
2024
Q4 		$647K Sell
21,709
-31,236
-59% -$661K 0.01% 655
2024
Q3 		$828K Buy
+52,945
New +$960K 0.01% 507
2024
Q2 		– Sell
-18,716
Closed -$293K – 1268
2024
Q1 		$293K Sell
18,716
-45,190
-71% -$665K 0.01% 795
2023
Q4 		$954K Buy
+63,906
New +$855K 0.02% 403
2023
Q3 		– Sell
-17,726
Closed -$736K – 1208
2023
Q2 		$736K Buy
17,726
+13,540
+323% +$841K 0.02% 446
2023
Q1 		$252K Buy
+4,186
New +$335K 0.01% 913
2022
Q3 		– Sell
-12,339
Closed -$857K – 1229
2022
Q2 		$857K Buy
+12,339
New +$929K 0.03% 489

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Quantinno Capital Management
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Graham Capital Management's NVCR Position: Q1 2026 in Review

Graham Capital Management sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 38,857 shares — an estimated $502K sold.

Graham Capital Management first reported a position in NVCR in Q2 2022 and held it in 11 quarters. The position peaked at $954K in Q4 2023. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Graham Capital Management reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Graham Capital Management sold 38,857 NovoCure shares in Q1 2026, an estimated $502K.
  • Graham Capital Management first reported a position in NovoCure in Q2 2022 and held it in 11 quarters.
  • Graham Capital Management's NovoCure position peaked at $954K in Q4 2023.
  • 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.